T1	chemical 63 72	inhibitor
T2	chemical 141 152	gemcitabine
T3	disease_or_phenotypic_feature 170 173	PDA
T4	chemical 228 234	Leptin
T5	disease_or_phenotypic_feature 257 264	obesity
T6	chemical 276 286	biological
T7	chemical 329 335	oxygen
T8	disease_or_phenotypic_feature 420 435	pulmonary edema
T9	disease_or_phenotypic_feature 441 449	seizures
T10	disease_or_phenotypic_feature 511 531	colon adenocarcinoma
T11	chemical 541 575	matrix metalloproteinase inhibitor
T12	chemical 630 634	drug
T13	chemical 652 662	biological
T14	chemical 718 727	cisplatin
T15	disease_or_phenotypic_feature 740 769	triple negative breast cancer
T16	chemical 811 819	estrogen
T17	disease_or_phenotypic_feature 830 837	obesity
T18	chemical 842 849	glucose
T19	disease_or_phenotypic_feature 884 887	MVD
T20	chemical 959 970	Factor VIII
T21	chemical 979 986	antigen
T22	chemical 1030 1040	biomarkers
T23	disease_or_phenotypic_feature 1044 1055	lung cancer
T24	chemical 1063 1067	food
T25	disease_or_phenotypic_feature 1088 1095	obesity
T26	disease_or_phenotypic_feature 1109 1122	Hyperglycemia
T27	disease_or_phenotypic_feature 1127 1143	hyperinsulinemia
T28	chemical 1196 1206	biological
T29	chemical 1208 1218	etanercept
T30	chemical 1254 1257	ras
T31	disease_or_phenotypic_feature 1258 1267	dependent
T32	chemical 1300 1303	ras
T33	chemical 1315 1325	antagonist
T34	chemical 1337 1351	growth hormone
T35	disease_or_phenotypic_feature 1386 1393	obesity
T36	chemical 1404 1414	biological
T37	disease_or_phenotypic_feature 1455 1460	NSCLC
T38	chemical 1474 1486	radiolabeled
T39	chemical 1526 1535	estradiol
T40	disease_or_phenotypic_feature 1557 1569	Cleft palate
T41	chemical 1617 1621	food
T42	chemical 1626 1631	water
T43	chemical 1633 1643	Fluoxetine
T44	disease_or_phenotypic_feature 1703 1710	obesity
T45	disease_or_phenotypic_feature 1715 1720	obese
T46	chemical 1741 1745	drug
T47	disease_or_phenotypic_feature 1771 1780	malignant
T48	disease_or_phenotypic_feature 1853 1868	hypopituitarism
T49	disease_or_phenotypic_feature 1901 1919	hypoparathyroidism
T50	disease_or_phenotypic_feature 1921 1938	diabetes mellitus
T51	chemical 1940 1954	growth hormone
T52	disease_or_phenotypic_feature 1967 1986	hyperprolactinaemia
T53	disease_or_phenotypic_feature 1988 2013	polycystic ovary syndrome
T54	chemical 2015 2019	SAHA
T55	disease_or_phenotypic_feature 2020 2028	syndrome
T56	disease_or_phenotypic_feature 2030 2060	congenital adrenal hyperplasia
T57	disease_or_phenotypic_feature 2062 2078	Cushing syndrome
T58	disease_or_phenotypic_feature 2113 2118	edema
T59	chemical 2136 2142	saline
T60	disease_or_phenotypic_feature 2161 2169	cataract
T61	chemical 2179 2182	dye
T62	chemical 2198 2208	Fluoxetine
T63	corrected_disease_or_phenotypic_feature 2262 2292	anxiety associated with autism
T64	disease_or_phenotypic_feature 2286 2292	autism
T65	missed_disease_or_phenotypic_feature 407 418	atelectasis
T66	corrected_chemical 318 335	hyperbaric oxygen
R1	causes_or_contributes_to Arg1:T66 Arg2:T65	
R2	causes_or_contributes_to Arg1:T66 Arg2:T8	
R3	causes_or_contributes_to Arg1:T66 Arg2:T9	
T67	missed_disease_or_phenotypic_feature 463 481	tumor angiogenesis
T68	missed_disease_or_phenotypic_feature 463 468;486 496	tumor metastasis
T69	corrected_disease_or_phenotypic_feature 500 531	C26 murine colon adenocarcinoma
R4	treats Arg1:T11 Arg2:T67	
R5	treats Arg1:T11 Arg2:T68	
R6	treats Arg1:T11 Arg2:T69	
T70	missed_chemical 577 585	KB-R7785
R7	treats Arg1:T70 Arg2:T67	
R8	treats Arg1:T70 Arg2:T68	
R9	treats Arg1:T70 Arg2:T69	
R10	treats Arg1:T14 Arg2:T15	
R11	causes_or_contributes_to Arg1:T16 Arg2:T17	
T72	missed_chemical 1186 1194	anti-TNF
R13	treats Arg1:T72 Arg2:T26	
R14	treats Arg1:T72 Arg2:T27	
T73	corrected_disease_or_phenotypic_feature 1254 1274	ras-dependent tumors
T74	corrected_chemical 1300 1325	ras-dislodging antagonist
R15	treats Arg1:T74 Arg2:T73	
R16	treats Arg1:T43 Arg2:T44	
T75	corrected_disease_or_phenotypic_feature 2107 2118	tumor edema
R17	causes_or_contributes_to Arg1:T59 Arg2:T75	
T76	missed_disease_or_phenotypic_feature 2237 2257;2270 2292	repetitive behaviors associated with autism
R18	treats Arg1:T62 Arg2:T76	
R19	treats Arg1:T62 Arg2:T63	
T77	corrected_chemical 63 94	inhibitor of cytidine deaminase
T78	missed_disease_or_phenotypic_feature 133 159	elevate gemcitabine levels
R20	causes_or_contributes_to Arg1:T77 Arg2:T78	
T79	missed_disease_or_phenotypic_feature 370 388	pulmonary toxicity
T80	missed_disease_or_phenotypic_feature 343 365;380 388	central nervous system toxicity
R21	causes_or_contributes_to Arg1:T66 Arg2:T80	
R22	causes_or_contributes_to Arg1:T66 Arg2:T79	
T71	corrected_disease_or_phenotypic_feature 1758 1788	disseminated malignant tumours
R12	treats Arg1:T46 Arg2:T71	
